Authors: Thylen, A Hjerpe, A Martensson, G

Citation: A. Thylen et al., Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma, CANCER, 92(5), 2001, pp. 1224-1230

Authors: Machado, RD Pauciulo, MW Thomson, JR Lane, KB Morgan, NV Wheeler, L Phillips, JA Newman, J Williams, D Galie, N Manes, A McNeil, K Yacoub, M Mikhail, G Rogers, P Corris, P Humbert, M Donnai, D Martensson, G Tranebjaerg, L Loyd, JE Trembath, RC Nichols, WC

Citation: Rd. Machado et al., BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension, AM J HU GEN, 68(1), 2001, pp. 92-102

Authors: Holmgren, D Asplund, EL Berggren, H Bergh, CH Eriksson, BO Martensson, G Nilsson, F

Citation: D. Holmgren et al., Thoracic organ transplantation in children - The Sahlgrenska University Hospital experience, SC CARDIOVA, 34(4), 2000, pp. 426-432

Authors: Riise, GC Andersson, BA Kjellstrom, C Martensson, G Nilsson, FN Ryd, W Schersten, H

Citation: Gc. Riise et al., Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant, EUR RESP J, 14(5), 1999, pp. 1123-1130

Authors: Andersen, MK Krarup-Hansen, A Martensson, G Winther-Nielsen, H Thylen, A Damgaard, K Olling, S Wallin, J

Citation: Mk. Andersen et al., Ifosfamide in malignant mesothelioma: a phase II study, LUNG CANC, 24(1), 1999, pp. 39-43

Authors: Thylen, A Wallin, J Martensson, G

Citation: A. Thylen et al., Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma, CANCER, 86(10), 1999, pp. 2000-2005